Genetics report companies by Prof. Roberto Grobman today: How we do it? We created a series of complex interconnected algorithms together with AI technology, capable of translating the scientific data and results of these scientific publications into useful information, and over the years we have been creating a unique FullDNA database. Our solution shows patients with a superior high accuracy rate what is written in their DNA, providing an excellent tool to understand what can happen and to act immediately to live longer and healthier. FullDNA provides an AI based customizable genetics prediction premium health tech platform to empower the capability of health professionals and institutions. FullDNA analyzes results from DNA sequencing Big Data using AI and complex algorithms to compares it with our own valuable extracted Database (updated daily) of more than 5,000 diseases and medical conditions, resulting in output of analysis & recommendation reports in various fields of medicine. See more info on https://issuu.com/robertogrobman.
How will hospitals and doctors be able to use our DNA data? Imagine if our doctor and the hospitals treating us had additional insights into our individual response to medication. The opportunity to enhance our treatment plan could be really beneficial. In practice, right now, that could happen with a doctor or patient sharing their pharmacogenomics report. In order to be effective at scale we would need to see pharmacogenomics results and reports stored in a patient’s electronic health record.
DNA report solutions with Prof. Roberto Grobman 2023: Risks and limitations: Tests may not be available for the health conditions or traits that interest you. This type of testing cannot tell definitively whether you will or will not get a particular disease. Results often need to be confirmed with genetic tests administered by a healthcare professional. The tests look only at a subset of variants within genes, so disease-causing variants can be missed. Unexpected information that you receive about your health, family relationships, or ancestry may be stressful or upsetting.
Consider the example of familial hypercholesterolemia (FH), a condition in which multiple variants of several different genes lead to markedly high cholesterol. This greatly increases the risk of heart attack, stroke, and other health problems. FH affects about one in 300 adults, which means it isn’t rare. Among adults who have the most common genetic variants that cause it, heart attack or sudden cardiac death may occur in middle age. Children who have a double dose of a gene variant linked to this condition may die of cardiovascular disease before age 20. Earlier treatments intended to reduce the risk of complications, such as cholesterol-lowering drugs, are available if a child or adult is known to have a mutation linked to FH.
These tests can often allow doctors to see what’s going on that they may not be observing in a physical examination — things that don’t manifest in the body. But such hereditary and congenital diseases are rare. DNA is not destiny: People are complex, and there are many things that affect someone’s health and ability to be healthy — from environmental to genetic. Your DNA is saying who you are—– not what you can and can’t be. And that’s an important message. For example, Andrew Steel, a 400-metre runner and former Olympian, discovered that he didn’t have what is called ‘the sprint gene’, one of a pair of genes that almost all other Olympic sprinters have. Had he been told at an early age ‘you don’t have this gene, so you’ll never amount to anything in sport’, he may not have gone on to become an Olympic medal-winning runner. The example also demonstrates the importance of reputable advice on how to interpret the results of DNA health tests.
Our entry-level genetic report encompasses a basic set of relevant genomic variants for a variety of Lifestyle & Personal Traits Panels. First Reports provide patient-specific information, determined by his genetics, which allows the user to know what their genetic tendencies are, thus can aid in maintaining their Vitality and Beauty. The startup FullDNA, which works with genetic recognition, will work with the University of Washington to help combat covid-19. The institution received first place in the Super Business Round in Vale do Pinhão. After the award, the company signed a collaboration agreement with a university in the United States to discover which elements are capable of interfering with the coupling of the coronavirus to the human cell receptor. Read even more info at Roberto Grobman.
